Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / HTBX - Heat Biologics secures new patent related to gp96 platform

HTBX - Heat Biologics secures new patent related to gp96 platform

Heat Biologics Inc.
Heat Biologics (HTBX) has been issued a new US patent (Patent No. 10,780,161) covering compositions of matter that are part of Heat's gp96 platform in combination with inducible T cell co-stimulator ligand, in a single therapy.This new patent compliments Heat's U.S. patents portfolio which also include a patent related to compositions of matter covering Heat's gp96 platform in combination with OX40L, a T cell costimulatory agonist.The company says it is progressing with Phase 1 trials with gp96 (HS-110) in combination with local OX40L (HS-130) and checkpoint inhibition as well as gp96-based COVID-19 vaccine.Shares are up 7% in premarket on modest volume

For further details see:

Heat Biologics secures new patent related to gp96 platform
Stock Information
Company Name: Heat Biologics Inc.
Stock Symbol: HTBX
Market: NASDAQ
Website: heatbio.com
Menu
HTBX HTBX Quote HTBX Short HTBX News HTBX Articles HTBX Message Board
Get HTBX Alerts

News, Short Squeeze, Breakout and More Instantly...